Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1996 1
1997 1
1998 1
1999 2
2000 2
2001 1
2002 1
2003 5
2004 6
2005 2
2006 8
2007 10
2008 8
2009 7
2010 6
2011 6
2012 7
2013 4
2014 6
2015 4
2016 9
2017 5
2018 9
2019 10
2020 15
2021 12
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Results by year
Filters applied: . Clear all
Page 1
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.
Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, Conradie F, Dalai D, van Deun A, Dat PT, Lan N, Master I, Mebrahtu T, Meressa D, Moodliar R, Ngubane N, Sanders K, Squire SB, Torrea G, Tsogt B, Rusen ID; STREAM Study Collaborators. Nunn AJ, et al. Among authors: van deun a. N Engl J Med. 2019 Mar 28;380(13):1201-1213. doi: 10.1056/NEJMoa1811867. Epub 2019 Mar 13. N Engl J Med. 2019. PMID: 30865791 Free article. Clinical Trial.
Multidrug-resistant tuberculosis.
Chiang CY, Van Deun A, Trébucq A, Piubello A, Schwoebel V, Rieder HL. Chiang CY, et al. Among authors: van deun a. Lancet. 2019 Jul 27;394(10195):299. doi: 10.1016/S0140-6736(19)30046-7. Lancet. 2019. PMID: 31354138 No abstract available.
How Second-Line Injectable Drugs Work.
Van Deun A, Decroo T. Van Deun A, et al. Clin Infect Dis. 2021 Jun 15;72(12):e1167-e1168. doi: 10.1093/cid/ciaa1874. Clin Infect Dis. 2021. PMID: 33341871 No abstract available.
Pretomanid for tuberculosis: a systematic review.
Gils T, Lynen L, de Jong BC, Van Deun A, Decroo T. Gils T, et al. Among authors: van deun a. Clin Microbiol Infect. 2022 Jan;28(1):31-42. doi: 10.1016/j.cmi.2021.08.007. Epub 2021 Aug 14. Clin Microbiol Infect. 2022. PMID: 34400340 Free article. Review.
First-line tuberculosis treatment with double-dose rifampicin is well tolerated.
Maug AKJ, Hossain MA, Gumusboga M, Decroo T, Mulders W, Braet S, Buyze J, Arango D, Schurmans C, Herssens N, Demeulenaere T, Lynen L, de Jong BC, Van Deun A. Maug AKJ, et al. Among authors: van deun a. Int J Tuberc Lung Dis. 2020 May 1;24(5):499-505. doi: 10.5588/ijtld.19.0063. Int J Tuberc Lung Dis. 2020. PMID: 32398199 Clinical Trial.
DOT, S, or DOTS?
Van Deun A, Rieder HL. Van Deun A, et al. Public Health Action. 2012 Mar 21;2(1):3-4. doi: 10.5588/pha.12.0007. Public Health Action. 2012. PMID: 26392936 Free PMC article. No abstract available.
Recurrence in tuberculosis: relapse or reinfection?
Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Lambert ML, et al. Among authors: van deun a. Lancet Infect Dis. 2003 May;3(5):282-7. doi: 10.1016/s1473-3099(03)00607-8. Lancet Infect Dis. 2003. PMID: 12726976 Review.
144 results